Consolidated Statement Of Shareholders' Equity - 9 months ended Mar. 31, 2016 - USD ($) shares in Thousands, $ in Thousands		Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Loss [Member]	Total Elizabeth Arden Shareholders' Equity [Member]	Noncontrolling Interest [Member]	Total
Balance at Jun. 30, 2015		$ 347	$ 375,796	$ (133,989)	$ (93,169)	$ (16,586)	$ 132,399	$ 91	$ 132,490
Balance, shares at Jun. 30, 2015		34,653			(4,841)
Issuance of restricted stock, net of forfeitures and tax withholdings		$ 1	250				251		251
Issuance of restricted stock, net of forfeitures and tax withholdings, shares		138
Amortization of share-based awards			4,136				4,136		4,136
Net (loss) income	[1]			(48,656)			(48,656)	137	(48,519)
Noncontrolling interest contribution at startup								63	63
Preferred stock dividends				(1,937)			(1,937)		(1,937)
Foreign currency translation adjustments						(2,881)	(2,881)		(2,881)	[2]
Net unrealized cash flow hedging loss						(1,614)	(1,614)		(1,614)	[3]
Balance at Mar. 31, 2016		$ 348	$ 380,182	$ (184,582)	$ (93,169)	$ (21,081)	$ 81,698	$ 291	$ 81,989
Balance, shares at Mar. 31, 2016		34,791			(4,841)

[1] Excludes the net loss for the redeemable noncontrolling interest which is recorded in the mezzanine section of the consolidated balance sheet. See Note 5.

[2] Foreign currency translation adjustments are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries.

[3] Net of tax benefit of $236 for the three months ended March 31, 2016, and net of tax expense of $75 for the three months ended March 31, 2015. Net of tax benefit of $56 for the nine months ended March 31, 2016 and net of tax expense $698 for the nine months ended March 31, 2015.